Showing results (61-70 of 156) with videos related to

Sort By:
Pageof 16
Translational Oncology|December 23, 2011
P21-activated kinase 4 overexpression in metastatic gastric cancer patientsHee Kyung Ahn, Jiryeon Jang, Jeeyun Lee, et al.
Cancer|August 31, 2010
Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitorsMyung Hee Chang, Hee Kyung Ahn, Jeeyun Lee, et al.
Cancer Research and Treatment|December 17, 2020
Implications of Tamoxifen Resistance in Palbociclib Efficacy for Patients with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Subgroup Analyses of KCSG-BR15-10 (YoungPEARL)Jiyun Lee, Seock-Ah Im, Gun Min Kim, et al.
Cancer Chemotherapy and Pharmacology|June 8, 2014
A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancerHee Kyung Ahn, Minkyu Jung, Sun Jin Sym, et al.
Cancer Research and Treatment|January 24, 2014
Nomogram to predict treatment outcome of fluoropyrimidine/platinum-based chemotherapy in metastatic esophageal squamous cell carcinomaHyun Ae Jung, Antoine Adenis, Jeeyun Lee, et al.
Cell|June 18, 2025
Interfamily co-transfer of sensor and helper NLRs extends immune receptor functionality between angiospermsXiaofei Du, Maheen Alam, Kamil Witek, et al.
Leukemia & Lymphoma|January 17, 2014
Symptom-oriented clinical detection versus routine imaging as a monitoring policy of relapse in patients with diffuse large B-cell lymphomaJunshik Hong, Ji Hyun Kim, Kyoung Hwa Lee, et al.
Asia-Pacific Journal of Clinical Oncology|June 23, 2010
Extraosseous osteosarcoma: single institutional experience in KoreaSoohyeon Lee, Mi Rae Lee, Su Jin Lee, et al.
Cancer Science|September 30, 2014
Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapyJunshik Hong, Hyun Seon Woo, Hyunchul Kim, et al.
Radiology|December 16, 2014
Volume-based metabolic tumor response to neoadjuvant chemotherapy is associated with an increased risk of recurrence in breast cancerSeung Hyup Hyun, Hee Kyung Ahn, Yeon Hee Park, et al.
Pageof 16